ID
36624
Description
Study ID: 102394 Clinical Study ID: 102394 Study Title: A Phase IV, partially double-blind study to demonstrate non-inferiority of GSK Biologicals’ Mencevax™ ACWY (new process) versus Mencevax™ ACWY (current process) when administered as a single dose to subjects aged 2-30 yrs Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00227422 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed clinical study under GSK sponsorship. The product that is studied in this clinical study, together with the rights to the data and results generated, has been transferred by GSK to Pfizer. GSK’s Clinical Study Register is no longer maintained for this study. To request access to clinical study data from Pfizer, go here: http://www.pfizer.com/research/clinical_trials/trial_data_and_results Generic Name: Meningococcal Serogroups A, C, W-135 and Y Vaccine Trade Name: Mencevax Study Indication: Infections, Meningococcal
Link
http://www.pfizer.com/research/clinical_trials/trial_data_and_results
Keywords
Versions (1)
- 5/26/19 5/26/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
May 26, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Mencevax™ ACWY (new process) versus Mencevax™ ACWY (current process); NCT00227422
Similar models
Concomitant Vaccination
- StudyEvent: ODM
C0042196 (UMLS CUI-2)
C0042196 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,2])
C2360065 (UMLS CUI [1,3])
C0042196 (UMLS CUI [1,2])
C0013153 (UMLS CUI [1,3])
C0042196 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
No comments